EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD STUDY AND LIBERTY-UC STUDY

Stefan Schreiber  ¹     Steve Hanauer  ²     William Sandborn  ³     Bruce E. Sands  ⁴     Silvio Danese  ⁵     Sang Joon Lee  ⁶     Sung Hyun Kim     Yunju Bae     Sunhee Lee     Seul Gi Lee     JoonHo Lee     Jong Min Kim     Siyoung Yang     Jimin Lee     Gahee Park     Juhyun Lee    
¹ University Hospital Schleswig-Holstein, Kiel, Germany
² Northwestern University/ Feinberg School of Medicine, Chicago, IL, United States
³ University of California San Diego, La Jolla, United States
⁴ Icahn School of Medicine at Mount Sinai, New York, United States
⁵ IRCCS San Raffaele Hospital, Milan, Italy
⁶ Celltrion, Inc, Incheon, Korea, Republic of

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)